SciELO - Scientific Electronic Library Online

 
vol.26 issue6Neurolytic procedures for pancreatic cancer pain: a systematic review and a proposal for an algorithm treatmentIntratecal baclophene for the treatment of pain and spasticity in stiff man syndrome: a case report author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

  • On index processCited by Google
  • Have no similar articlesSimilars in SciELO
  • On index processSimilars in Google

Share


Revista de la Sociedad Española del Dolor

Print version ISSN 1134-8046

Abstract

MUGABURE BUJEDO, B. Key factors influencing bioavailability of opioides in the spinal cord for the management of acute pain. Rev. Soc. Esp. Dolor [online]. 2019, vol.26, n.6, pp.359-367.  Epub Mar 30, 2020. ISSN 1134-8046.  https://dx.doi.org/10.20986/resed.2019.3737/2019.

Although there is no either ideal analgesic or route of neuraxial administration, clinicians alike continue to search for compounds with qualities which may approach this idea. However, it´s a demonstrated fact that spinal administration of an opioid drug does not always guarantee segmental and selective analgesia into the spinal cord. This point is valid due to partial reuptake of the drug to systemic blood circulation reaching specific brain opioid receptors, rather than the differences are explained by variations in the clearance rate from the cerebrospinal fluid. Published evidence from either human or animal experimental studies indicates that bioavailability in the spinal cord biophase is negatively correlated with liposolubility. Therefore, opioid spinal cord bioavailability is higher for hydrophilic opioids like morphine, than for lipophilic ones such as fentanyl, sufentanil or alfentanil.

Keywords : Analgesics; opioids; biological availability; opioid receptors; acute pain; spinal cord.

        · abstract in Spanish     · text in English | Spanish     · English ( pdf ) | Spanish ( pdf )